2016
DOI: 10.1016/j.ccc.2016.02.004
|View full text |Cite
|
Sign up to set email alerts
|

The Circulatory System in Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
11
0
3

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 38 publications
2
11
0
3
Order By: Relevance
“…As shown within the present dataset, some degree of allograft dysfunction is common after IHR. Even moderate degrees of hepatic dysfunction can affect renal perfusion through systemically altered vascular response [26] ; decreased hepatic metabolism causes a surplus of vasodilatory nitric oxide and endothelial factors that decrease systemic vascular resistance and activate the renin-angiotensin system 27 , 28 . Exacerbating this effect is a derivative increase in splanchnic resistance.…”
Section: Discussionmentioning
confidence: 99%
“…As shown within the present dataset, some degree of allograft dysfunction is common after IHR. Even moderate degrees of hepatic dysfunction can affect renal perfusion through systemically altered vascular response [26] ; decreased hepatic metabolism causes a surplus of vasodilatory nitric oxide and endothelial factors that decrease systemic vascular resistance and activate the renin-angiotensin system 27 , 28 . Exacerbating this effect is a derivative increase in splanchnic resistance.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with end-stage liver disease, hyperdynamic circulation is manifested in patients with end-stage liver disease as elevated cardiac output and heart rate, and reduced systemic vascular resistance with normal or decreased MAP. [ 31 ] Although overall splanchnic vascular resistance decreases, no decrease in vascular resistance is demonstrated in whole vascular beds [ 32 ] including the kidneys. [ 33 ] Renal vasoconstriction is caused by effective hypovolemia and neurohormonal activation in patients with cirrhosis.…”
Section: Discussionmentioning
confidence: 99%
“…During the expression of the endocrine inflammatory phenotype in TPVL-rats there is a splanchnic remodeling by angiogenesis, which implies growth of new vessels from pre-existing ones[59], and fibrosis. Moreover, an abnormal splanchnic and systemic angioarchitecture, such as portosystemic collaterals have been observed in chronic liver diseases[60-62].…”
Section: The Endocrine Inflammatory Phenotypementioning
confidence: 99%